Latest news
Showing 24/25 results
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer
Tue 6 Jun 2023
CN-Bio Innovations
CN Bio appoints Deepak Singh as Vice
Tue 14 Mar 2023
CN-Bio Innovations
CN Bio appoints Deepak Singh as Vice President of Sales and Marketing
Tue 14 Mar 2023
CN-Bio Innovations
CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System
Thu 2 Mar 2023
CN-Bio Innovations
The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system
Sun 22 Jan 2023
CN-Bio Innovations
CN Bio appoints Dr Paul Brooks as Chief Executive Officer
Mon 19 Dec 2022
CN-Bio Innovations
CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities
Tue 19 Jul 2022
CN-Bio Innovations
PhysioMimix NASH ‘in-a-box’ reagent kit
Fri 29 Apr 2022
CN-Bio Innovations
Debunking the 9 Myths of Organ-on-a-Chip Technology
Mon 28 Feb 2022
CN-Bio Innovations
PhysioMimix™ Multi-Organ Microphysiological System selected by The Scientist as a ‘Top 10 Innovation 2021′
Wed 1 Dec 2021
CN-Bio Innovations
CN Bio and iiCON announce COVID-19 research collaboration
Tue 9 Nov 2021
CN-Bio Innovations
CN Bio expands service offering to support oncology drug discovery
Tue 5 Oct 2021
CN-Bio Innovations
CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University
Mon 2 Aug 2021
CN-Bio Innovations
Lonza and CN Bio Announce Distribution Agreement
Tue 20 Jul 2021
CN-Bio Innovations
CN Bio’s PhysioMimix™ adopted by King’s College London to investigate chronic liver disease
Wed 7 Jul 2021
CN-Bio Innovations
CN Bio FDA collaboration expanded
Tue 11 May 2021
CN-Bio Innovations
Introducing the PhysioMimix™ OOC Multi-Organ Microphysiological System
Mon 22 Mar 2021
CN-Bio Innovations
CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research
Mon 8 Mar 2021
CN-Bio Innovations
How novel an in vitro Liver-on-a-Chip model of fatty liver disease is being used to help prevent a global healthcare crisis
Mon 1 Feb 2021
CN-Bio Innovations
CN Bio’s PhysioMimix™ technology receives FDA recognition
Mon 18 Jan 2021
CN-Bio Innovations
CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients
Mon 4 Jan 2021
CN-Bio Innovations
CN Bio to provide drug metabolism and safety toxicity testing services
Mon 9 Nov 2020
CN-Bio Innovations
CN Bio and Imperial College London Collaboration
Tue 8 Sep 2020
CN-Bio Innovations
CN Bio makes key senior appointments to support international commercial development
Mon 10 Aug 2020
CN-Bio Innovations